Entrada Therapeutics Inc.
TRDA | NASDAQ
$6.75
+$0.11 (+1.66%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 898K | 875K | 1.3M | 1.61M | 1.95M | 20.56M | 37.4M | 19.57M | 94.69M | 59.12M | 41.85M | 43.74M | 18.17M | 25.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 805K | 886K | 38.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22.19M | 26.3M | 23.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 898K | 70K | 413K | -36.75M | 1.95M | 20.56M | 37.4M | 19.57M | 94.69M | 59.12M | 41.85M | 21.54M | -8.13M | 2.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -44.96M | -42.3M | -42.21M | -47.05M | -46.85M | -21.79M | -5.87M | -21.66M | 53.42M | 21.11M | 4.91M | 14.01M | -16.3M | -5.78M | -25.58M | -25.94M | -23.58M | -22.15M | -18.46M | -14.36M | -9.91M | -8.39M |
Interest Income | 2.24M | 2.62M | 3.14M | 3.57M | 3.92M | 4.44M | 5.13M | 5.77M | 4.37M | 4.21M | 4.29M | 4.05M | 4.22M | 2.66M | n/a | 799K | 403K | 480K | 13K | n/a | 9K | 13K |
Pretax Income | -42.73M | -39.68M | -39.07M | -43.48M | -42.93M | -17.35M | -739K | -15.89M | 57.79M | 25.33M | 9.2M | 52.86M | -12.08M | -3.12M | -24.63M | -25.14M | -23.18M | -21.67M | -18.45M | -14.43M | -9.9M | -8.38M |
Net Income | -42.76M | -39.72M | -39.16M | -44.13M | -43.1M | -17.35M | 1.13M | -14.03M | 55.03M | 23.5M | -9.54M | 35.46M | -25.93M | -6.67M | -24.63M | -25.14M | -23.18M | -21.67M | -18.45M | -14.43M | -9.9M | -8.38M |
Selling & General & Admin | 10.49M | 10.12M | 9.55M | 10.3M | 10.92M | 10.27M | 9.86M | 9.97M | 9.24M | 9.4M | 8.65M | 7.53M | 8.17M | 7.94M | 9.89M | 6.98M | 7.33M | 6.43M | 6.1M | 3.85M | 3.08M | 2.17M |
Research & Development | 35.37M | 33.05M | 33.96M | 38.36M | 37.88M | 32.07M | 33.41M | 31.26M | 32.04M | 28.61M | 28.29M | 22.19M | 26.3M | 23.1M | 15.69M | 18.96M | 16.25M | 15.72M | 12.36M | 10.51M | 6.83M | 6.22M |
Other Expenses | n/a | -805K | -886K | -38.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.19M | -26.3M | -23.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 45.86M | 42.37M | 42.62M | 10.3M | 48.8M | 42.35M | 43.27M | 41.23M | 41.27M | 38.01M | 36.94M | 7.53M | 8.17M | 7.94M | 25.58M | 25.94M | 23.58M | 22.15M | 18.46M | 14.36M | 9.91M | 8.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 66K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 45.86M | 43.18M | 43.51M | 48.67M | 48.8M | 42.35M | 43.27M | 41.23M | 41.27M | 38.01M | 36.94M | 29.72M | 34.47M | 31.04M | 25.58M | 25.94M | 23.58M | 22.15M | 18.46M | 14.36M | 9.91M | 8.39M |
Income Tax Expense | 35K | 38K | 92K | 654K | 178K | n/a | -1.87M | -1.86M | 2.76M | 1.83M | 18.74M | 17.4M | 13.85M | 3.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 42.22M | 41.84M | 41.37M | 41.46M | 41.34M | 41.07M | 40.84M | 40.63M | 34.18M | 33.5M | 33.37M | 33.28M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
Shares Outstanding (Diluted) | 42.22M | 41.84M | 41.37M | 41.46M | 41.34M | 41.07M | 43.05M | 40.63M | 35.51M | 34.79M | 33.37M | 34.78M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
EPS (Basic) | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 | -0.29 | 1.07 | -0.78 | -0.21 | -0.71 | -0.75 | -0.72 | -0.66 | -0.89 | -0.51 | -0.48 | -0.41 |
EPS (Diluted) | -1.01 | -0.95 | -0.95 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.55 | 0.68 | -0.29 | 1.02 | -0.78 | -0.21 | -0.71 | -0.75 | -0.72 | -0.66 | -0.89 | -0.51 | -0.48 | -0.41 |
EBITDA | -41.89M | -38.87M | -41.86M | -42.25M | -41.89M | -16.4M | 253K | -14.96M | 58.7M | 26.26M | 9.93M | 53.69M | -11.35M | -2.58M | -24.1M | -24.62M | -22.72M | -21.28M | -18.08M | -14.06M | -9.65M | -8.19M |
EBIT | -42.73M | -39.68M | -39.07M | -43.48M | -42.93M | -17.35M | -739K | -15.89M | 57.79M | 25.33M | 9.2M | 52.86M | -12.08M | -3.12M | -24.63M | -25.14M | -23.18M | -21.67M | -18.45M | -14.36M | -9.9M | -8.39M |
Depreciation & Amortization | 841K | 805K | -2.79M | 1.23M | 1.03M | 946K | 992K | 937K | 910K | 934K | 736K | 834K | 730K | 541K | 525K | 516K | 463K | 390K | 364K | 302K | 252K | 199K |
Add to Watchlist
Select watchlists to add or remove TRDA